PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

New psychopharmacology research finds women are more sensitive to some of the effects of methamphetamine

by Eric W. Dolan
October 5, 2019
Reading Time: 3 mins read
(Photo credit: Johanna Goodyear)

(Photo credit: Johanna Goodyear)

Share on TwitterShare on Facebook

Woman tend to be more sensitive to the psychomotor-related behavioral and subjective effects of methamphetamine than men, according to a new study published in the journal Psychopharmacology. The findings could help explain why women tend to transition from recreational methamphetamine use to dependence more quickly.

“We were interested in exploring individual differences in acute or early drug responses, prior to the development of a drug use disorder,” explained study author Leah Mayo, a postdoctoral research fellow at Linköping University in Sweden.

“While many people will try drugs throughout their life, only a minority (albeit, a significant minority) will develop a substance use disorder. Doing studies like these in healthy, non-dependent humans allows us to understand how people vary in response to a drug and how that variation may make them more vulnerable, or resilient, to the development of a drug use disorder.”

“In particular, clinical and epidemiological reports suggest that women are more vulnerable to developing a methamphetamine use disorder. However, it is unclear what contributes to these different drug use trajectories. Here, we asked whether gender differences in response to methamphetamine exist early on, prior to the development of problematic use.”

In the study, 44 men and 29 women completed four sessions in which they received either placebo or methamphetamine (20 mg) under double-blind conditions.

About 30 minutes into each session, the participants completed a monetary incentive delay in which they had to respond quickly to a target in order to win or avoid losing money. The participants also completed assessments of mood and drug effects, and the researchers monitored their blood pressure and heart rate.

“We find that women are more sensitive to psychomotor-related effects of methamphetamine than men. In particular, women report feeling more ‘vigor’ and less ‘fatigue’ after taking the drug. Behaviorally, they also show faster reaction times in a reward-processing task,” Mayo told PsyPost.

“Together, we propose that this heightened sensitivity to the behavioral and subjective effects of methamphetamine in women may render them more likely to use the drug again, and perhaps escalate use over time. This supports clinical data showing that female methamphetamine users transition more quickly from recreational use to dependence than their male counterparts.”

Google News Preferences Add PsyPost to your preferred sources

The findings provide some new insights into the effects of methamphetamine, but more research is needed to clarify the relationship between these effects and addiction.

“We have shown that women are more sensitive to some of the effects of methamphetamine and we hypothesize that this sensitivity may render them more vulnerable to develop problematic use patterns. However, we still don’t know if this is true; that is, are those most sensitive to these drug effects actually the ones who are more vulnerable to developing a use disorder?” Mayo explained.

“We also don’t know how these effects change over time. More specifically, how do the behavioral and subjective responses to methamphetamine change as drug use escalates? There are still many clinical questions to be answered, but we hope that this study provides a starting point for understanding gender-based differences in methamphetamine effects and consumption.”

“One interesting observation is that the differences we report between men and women seem to be specific to methamphetamine. Work from others suggest that similar gender differences are not evident in response the closely related drug, D-amphetamine,” Mayo added.

“Strikingly, very similar effects have been reported in preclinical animal models: psychomotor effects of methamphetamine, but not D-amphetamine, differ between male and female rodents. The fact that this sex-based difference also exists in preclinical animal models opens up the avenue for gaining a more mechanistic understanding of the neurobiological underpinnings of these behaviors.”

The study, “Gender differences in the behavioral and subjective effects of methamphetamine in healthy humans“, was authored by Leah M. Mayo, Elisabeth Paul, Jessica DeArcangelis, Kathryne Van Hedger, and Harriet de Wit.

RELATED

Psychedelic mushroom extract may offer enhanced brain benefits over synthetic psilocybin
Psilocybin

Estrogen levels may dictate how the brain reacts to psychedelics, new animal study indicates

May 14, 2026
Little-known psychedelic drug reduces motivation to take heroin in rats, study finds
Psychedelic Drugs

Are the benefits of psychedelics exaggerated? A new study highlights the problem of selection bias

May 12, 2026
Psychedelic therapy ignited a harrowing mental health crisis for one patient — but she would do it again
Psychedelic Drugs

New study explores the link between mystical psychedelic trips and a reduced fear of dying

May 11, 2026
Childhood ADHD traits linked to midlife distress, with societal exclusion playing a major role
Psychedelic Drugs

Real world outcomes support the benefits of psychedelic therapy for severe depression

May 9, 2026
Study finds microdosing LSD is not effective in reducing ADHD symptoms
Depression

LSD microdosing linked to acute mood improvements in adults with depression

May 8, 2026
Novel psychedelic compound 25C-NBF shows rapid antidepressant effects without addictive traits
Psychedelic Drugs

Novel psychedelic compound 25C-NBF shows rapid antidepressant effects without addictive traits

May 6, 2026
Psychedelic science breakthrough: Increased brain entropy from psilocybin predicts lasting psychological insight and well-being
Neuroimaging

Psychedelic science breakthrough: Increased brain entropy from psilocybin predicts lasting psychological insight and well-being

May 5, 2026
People with cannabis use disorder are more likely to be depressed, study finds
Cannabis

People with cannabis use disorder are more likely to be depressed, study finds

May 5, 2026

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader. We also syndicate to Apple News.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • The human brain processes the passage of time across three distinct stages
  • Brain scans identify the neural network that traps anxious people in cycles of self-blame
  • New study finds sustainable living relies on stable personality traits, not temporary bursts of willpower
  • Brooding identified as a major driver of bedtime procrastination, alongside physical markers of stress
  • Scientists challenge The Body Keeps the Score with a new predictive model of trauma

Science of Money

  • When illness leads to illegality: How a cancer diagnosis reshapes the decision to commit a crime
  • The Goldilocks zone of sales pressure: Why a little urgency helps and too much hurts
  • What women really want from “girl power” ads: Six ingredients that make femvertising work
  • The seductive allure of neuroscience: Why brain talk feels so satisfying, even when it explains nothing
  • When two heads aren’t better than one: What research reveals about human-AI teamwork in marketing

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc